Ten years of NovoMix 30 in Russian and international clinical practice
Insulin treatment for type 2 diabetes mellitus is challenging in elderly people. Biphasic insulin preparations technically simplify this task, but also increase compliance and facilitate the achievement of therapeutic goals.
Guardado en:
Autor principal: | Elena Viktorovna Surkova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd60a5d18b7d4f7481e31e3f4235ee25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
por: Elena Viktorovna Surkova
Publicado: (2013) -
Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
por: Yury Ivanovich Filippov, et al.
Publicado: (2012) -
Insulin degludec is a new ultra-long-acting insulin analogue
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014) -
Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2013) -
Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: resultsfrom a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 inroutine clinical practice
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2010)